Ben Derman

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

November, 2024

Ben Derman

Jul 14, 2024, 02:56 | Drugs

Belamaf-based triplet regimens are effective in patients with R/R multiple myeloma - ASCO

ASCO shared on X: "The DREAMM-7 and DREAMM-8 studies established the effectiveness of belamaf-based triplet…

Jun 12, 2024, 05:15 | Blog

Brand new episode on updates in Myeloma MRD - Blood Cancer Talks

Ben Derman, Assistant Professor at the University of Chicago, recently shared a post by Blood…

May 31, 2024, 09:24 | Insight

Vincent Rajkumar: International Myeloma Working Group guidelines CAR-T cell treatment in myeloma by Yi Lin

Vincent Rajkumar shared on X: "Just out: International Myeloma Working Group guidelines CAR-T cell treatment…

Apr 18, 2024, 13:58 | Insight

Ben Derman: Should MRD negativity be accepted as a surrogate endpoint for clinical trials in myeloma

Ben Derman, Assistant Professor at the University of Chicago, shared on X/Twitter: "Should MRD negativity…

Aug 16, 2023, 19:07 | Drugs

Ben Derman: Some thoughts on Elrantamab in light of approval.

Dr. Ben Derman, Assistant Professor at the University of Chicago, recently shared in a Twitter…

All: 5 Posts: 1 - 100

Dr. Richard Pazdur's 25 Year WAR on Cancer at the FDA!

China Anti-Cancer Association (CACA) and OncoDaily Announce Strategic Partnership to Advance Global Cancer Care

Donald Trump: Thrilled to announce Robert F. Kennedy Jr. as The United States Secretary of HHS

Overview of ASCO Breakthrough

Robert De Niro and Prostate Cancer: How He Went Against, How He Survived, and More

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023